Table 2.
Distal Jejunum |
Distal Colon |
|||||||
---|---|---|---|---|---|---|---|---|
HA |
PEP-1 |
HA |
PEP-1 |
|||||
Gene | Fold Δ | P value | Fold Δ | P value | Fold Δ | P value | Fold Δ | P value |
IGF1 | NSD | −1.8 | 0.035 | +2.6 | 0.038 | NSD | ||
IGFBP5 | NSD | −2.5 | 0.028 | +1.4 | 0.039 | NSD | ||
FGF2 | NSD | NSD | +2.1 | 0.047 | NSD | |||
FGF4 | +1.5 | 0.045 | NSD | NSD | NSD | |||
FGF8 | NSD | NSD | +2.4 | 0.025 | NSD | |||
EGF | +3.2 | 0.022 | NSD | NSD | NSD | |||
Epiregulin | NSD | NSD | NSD | −1.5 | 0.040 | |||
HAS1 | +6.3 | 0.004 | NSD | +6.0 | 0.002 | NSD | ||
HYAL3 | +1.4 | 0.025 | NSD | +2.0 | 0.042 | NSD |
Values are means ± SE; n = 4 mice for all genes. Mice were given hyaluronic acid (HA) or PEP-1 intraperitoneally twice a week for 5 wk starting at weaning. mRNA was extracted from distal jejunums and distal colons and used in RT-PCR. In HA-treated mice, there was increased gene expression for growth factors in intestine (FGF4 and FGF8) and colon [IGF1 (IGF-I), IGFBP5, and FGF2]; there was also increased expression of genes for HA synthesis (HAS1) and HA degradation (HYAL3) in intestine and colon. In mice treated with PEP-1, there was decreased gene expression for growth factors in intestine (IGF-I and IGFBP5) and colon (epiregulin), but there was no change in HAS or HYAL genes. NSD, no significant difference.